While North America currently holds the largest share of the Preimplantation Genetic Testing Market , the most dynamic growth is occurring in the Asia-Pacific (APAC) region. Valued at USD 0.55 billion in 2024 and projected to reach USD 1.2 billion by 2035, the APAC market is the fastest-growing in the world, fueled by a powerful combination of rising infertility rates, economic development, and increasing social acceptance of assisted reproductive technologies.

A primary driver in APAC is the sheer scale of the population and the rapidly modernizing lifestyles in countries like China and India. Delayed marriage and childbearing, coupled with increasing environmental and lifestyle factors, are contributing to a significant rise in infertility. This creates a massive and growing patient base seeking fertility treatments. Simultaneously, rising disposable incomes in the expanding middle class mean that more couples can afford advanced procedures like IVF, which were previously out of financial reach.

The region is also becoming a global hub for medical tourism, particularly for fertility care. Countries like Thailand, India, and Singapore offer high-quality medical services at a fraction of the cost in Western nations, attracting patients from across the region and beyond. These international patients often seek comprehensive packages that include advanced genetic testing, further boosting the demand for PGT services.

Furthermore, there is a gradual but significant shift in cultural attitudes. While discussions around reproductive health and genetic testing were once taboo, increasing awareness campaigns and media coverage are leading to greater openness. Educational initiatives, supported by international health organizations, are highlighting the benefits of PGT in preventing hereditary diseases. The UNICEF reports that increasing awareness of genetic disorders and reproductive health services has contributed to a steady rise in the utilization of prenatal and preconception screening programs across more than 100 countries, including many in APAC. As healthcare infrastructure continues to improve and societal acceptance grows, the APAC region is poised to reshape the global PGT market landscape.